FormWeb • rosuvastatin-ezetimibe

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

rosuvastatin-ezetimibe

rosuvastatin-ezetimibe

Non-formulary HMG CoA Reductase Inhibitor Formulary
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Roszet	TABLET, ORAL	10 mg/5 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

rosuvastatin-ezetimibe (Roszet)

5 mg-10 mg tablet

10 mg-10 mg tablet
20 mg-10 mg tablet
40 mg-10 mg tablet

ezetimibe (Zetia) AND atorvaSTATin (Lipitor)

10 mg ezetimibe tablet PLUS 10 mg atorvaSTATin
10 mg ezetimibe tablet PLUS 20 mg atorvaSTATin
10 mg ezetimibe tablet PLUS 40 mg atorvaSTATin

10 mg ezetimibe tablet PLUS 80 mg atorvaSTATin

Reviewed: June 2021 (Roszet)

Last updated: Sep. 17, 2021

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.